Ryosuke Kurokawa

This inventor holds 9 USPTO granted patents and 11 published patent applications and 2 EPO patents. Top assignees: Miz Company Limited, Incorporated Medical Institution Yukokai, Osaka University. Active years: 2013-2022.

USPTO Granted Patents = 9 (Patent Applications = 11)

% Patents Active = 11.1

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 38(Granted Patents)

Company Filing History:

Incorporated Medical Institution Yukokai

where one patent can have more than one assignee

Years Active: 2013-2022

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11529367 - Radiation damage protective agent (2022-12-20),

2. 11033574 - Method for treating schizophrenia (2021-06-15),

3. 11026967 - Composition for suppressing or preventing abnormality in intestinal environment (2021-06-08),

4. 10238232 - Selective hydrogen adding equipment for living organism applicable fluid (2019-03-26),

5. 9149774 - Selective hydrogen adding equipment for living organism applicable fluid (2015-10-06),

6. 9120672 - Selective hydrogen adding equipment for living organism applicable fluid (2015-09-01),

7. 9108871 - Selective hydrogen adding equipment for living organism applicable fluid (2015-08-18),

8. 8887625 - Hydrogen adding equipment for living organism applicable fluid (2014-11-18),

9. 8574503 - Instrument for nondestructively producing high-concentration hydrogen solution (2013-11-05),

Title: Ryosuke Kurokawa: Innovator in Radiation Protection and Mental Health Treatment

Introduction

Ryosuke Kurokawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the fields of radiation protection and mental health treatment. With a total of 9 patents to his name, Kurokawa's work is characterized by innovative approaches to complex medical challenges.

Latest Patents

Among his latest patents is a radiation damage protective agent. This agent comprises hydrogen gas as an active ingredient at a concentration of 18.5% by volume or less. It is designed for treating or alleviating radiation damage in human patients exposed to radiation or undergoing radiotherapy, particularly when administered in a hyperbaric capsule under higher than standard atmospheric pressure. Another significant patent is a method for treating schizophrenia. This method involves administering a composition containing a therapeutically effective amount of hydrogen gas to a subject in need of treatment through inhalation.

Career Highlights

Kurokawa has worked with various organizations, including Miz Company Limited and Osaka University. His career reflects a commitment to advancing medical technology and improving patient outcomes through innovative solutions.

Collaborations

Some of his notable coworkers include Fumitake Satoh and Tomoki Seo. Their collaborative efforts have contributed to the development of groundbreaking treatments in their respective fields.

Conclusion

Ryosuke Kurokawa's contributions to innovation in radiation protection and mental health treatment highlight his role as a leading inventor. His work continues to impact the medical community positively, paving the way for future advancements.